Kingstone Capital Partners Texas, LLC Gilead Sciences, Inc. Transaction History
Kingstone Capital Partners Texas, LLC
- $624 Billion
- Q2 2025
A detailed history of Kingstone Capital Partners Texas, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Kingstone Capital Partners Texas, LLC holds 2,147,411 shares of GILD stock, worth $258 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
2,147,411Holding current value
$258 Million% of portfolio
0.03%Shares
1 transactions
Others Institutions Holding GILD
# of Institutions
2,298Shares Held
1BCall Options Held
9.42MPut Options Held
9.72M-
Black Rock Inc. New York, NY121MShares$14.5 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA119MShares$14.3 Billion0.22% of portfolio
-
State Street Corp Boston, MA59.5MShares$7.14 Billion0.28% of portfolio
-
Capital World Investors Los Angeles, CA46.3MShares$5.56 Billion0.78% of portfolio
-
Capital Research Global Investors Los Angeles, CA31.1MShares$3.73 Billion0.72% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $150B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...